Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-071369
Filing Date
2008-03-31
Accepted
2008-03-31 17:21:57
Documents
8
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 2016434
2 LIST OF SUBSIDIARIES dex211.htm EX-21.1 4171
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 2000
4 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER REQUIRED BY RULE 13A-14(A) dex311.htm EX-31.1 9477
5 CERTIFICATIONS OF CHIEF FINANCIAL OFFICER REQUIRED BY RULE 13A-14(A) dex312.htm EX-31.2 9498
6 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER REQUIRED BY RULE 13A-14(B) dex321.htm EX-32.1 3074
7 CERTIFICATIONS OF CHIEF FINANCIAL OFFICER REQUIRED BY RULE 13A-14(B) dex322.htm EX-32.2 3074
8 GRAPHIC g26625g56m19.jpg GRAPHIC 42812
  Complete submission text file 0001193125-08-071369.txt   2108255
Mailing Address 10398 PACIFIC CENTER COURT SAN DIEGO CA 92121
Business Address 10398 PACIFIC CENTER COURT SAN DIEGO CA 92121 858 410 4600
NANOGEN INC (Filer) CIK: 0001030339 (see all company filings)

EIN.: 330489621 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23541 | Film No.: 08726252
SIC: 3826 Laboratory Analytical Instruments